£20
1 period on recordActive15738538Private limited companyEast Molesey
LYKKE RESEARCH LTD
Significant control: Geoffrey Robert Dixon (25–50%), Peter Andrew Whitton (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Lykke Research Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Lykke Research Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
LYKKE RESEARCH LTD is an active private limited company (company number 15738538) incorporated on 24 May 2024, registered in East Molesey. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 May 2025, showing net assets of £20 and cash of £20.
Peer position · net assets
By net assets it sits in the lower half of 151 comparable companies in Greater London (median £200, upper quartile £53k).
02
Ownership and control
- Mr Geoffrey Robert Dixon
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Peter Andrew Whitton
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 24 May 20242 yrs ago
- Next accounts due
- 28 February 2027in 126 days
- Confirmation statement due
- 7 June 2027in 225 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
05
Financials
£20
1 period on recordNot reported
Not reported
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | £20 | £20 | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £20 at 31 May 2025
- Incorporated two to five years agoIncorporated 24 May 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 225 days
- Next accounts duein 126 days
- Accounts period endNet assets £20 · dormant accounts
- Incorporated
08
Similar companies in Greater London
- CAPSID BIOTECHNOLOGY LTDWaltham Abbey · inc. May 2024
- SWIFT NEURO CONSULTING LTDPotters Bar · inc. May 2024
- ONCOMMITTMENT LIMITEDHarrow · inc. Jun 2024
- EBIXIGEN LIMITEDRuislip, · inc. Mar 2024
- ORTO BIO LIMITEDKingston Upon Thames · inc. Mar 2024
- RESIGENIX LTDFeltham · inc. Mar 2024
All companies incorporated on 24 May 2024 · in May 2024.
09
Reminders for LYKKE RESEARCH LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.